Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALI - Acute Lung Injury”

420 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 420 results

Not applicableStudy completedNCT04750369
What this trial is testing

Enhanced Triage for COVID-19

Who this might be right for
COVID-19SARS-CoV 2
University Health Network, Toronto 806
Not applicableStudy completedNCT07368868
What this trial is testing

Effect of Initiation of Veno-venous ECMO on Urine Output and Acute Kidney Injury

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)Acute Kidney InjuryECMO
University Hospital, Ghent 76
Not applicableNot Yet RecruitingNCT07309783
What this trial is testing

Lung EIT Image Guide Ventilation in ARDS

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
Peking Union Medical College Hospital 574
Not applicableStudy completedNCT03315702
What this trial is testing

Effect of Mechanical Ventilation on Plasma Concentration Level of R-spondin Proteins

Who this might be right for
Acute Lung Injury
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 52
Post-approval studies (Phase 4)Study completedNCT00219375
What this trial is testing

Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan

Who this might be right for
Acute Lung InjurySystemic Inflammatory Response Syndrome
Ono Pharmaceutical Co., Ltd. 649
Testing effectiveness (Phase 2)Looking for participantsNCT06701656
What this trial is testing

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Who this might be right for
Acute Respiratory Distress Syndrome (ARDS)ARDSARDS (Acute Respiratory Distress Syndrome)+1 more
PPD Development, LP 200
Testing effectiveness (Phase 2)Study completedNCT01627613
What this trial is testing

Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

Who this might be right for
Acute Lung Injury
Apeptico Forschung und Entwicklung GmbH 40
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Testing effectiveness (Phase 2)Study completedNCT00879606
What this trial is testing

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Who this might be right for
SepsisAcute Lung InjuryAcute Respiratory Distress Syndrome
Altor BioScience 150
Not applicableUnknownNCT00639990
What this trial is testing

Respiratory Mechanics in Brain Injured Patients

Who this might be right for
Brain InjuryAcute Lung Injury
Università degli Studi dell'Insubria 40
Not applicableUnknownNCT04750096
What this trial is testing

Esophagectomy Enhanced Recovery After Surgery Protocol

Who this might be right for
Esophagectomy
Raquel Ferrandis Comes 100
Not applicableNot Yet RecruitingNCT07603310
What this trial is testing

Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Patients.

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
Hospital Dr. Franco Ravera Zunino 52
Not applicableLooking for participantsNCT06045780
What this trial is testing

HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

Who this might be right for
Sepsis
Tianjin Nankai Hospital 150
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Very early researchLooking for participantsNCT07558538
What this trial is testing

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital 24
Not applicableStudy completedNCT00747045
What this trial is testing

Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionAcute Lung Injury
University of California, San Diego 128
Not applicableStudy completedNCT01159392
What this trial is testing

Alveolar Recruitment in Brain Injury

Who this might be right for
Brain InjuryAcute Lung Injury
Hospital Clinic of Barcelona 9
Testing effectiveness (Phase 2)Study completedNCT00852605
What this trial is testing

Acute Lung Injury After Allogeneic Transplantation - Diagnosis and Early Treatment

Who this might be right for
Acute Lung Injury
Technische Universität Dresden 86
Early research (Phase 1)Study completedNCT01640990
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

Who this might be right for
Lung Injury, Acute
GlaxoSmithKline 3
Not applicableStudy completedNCT05012267
What this trial is testing

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).

Who this might be right for
Ards
Ignacio Saez de la Fuente 61
Load More Results